271 related articles for article (PubMed ID: 28720877)
1. Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1/angiotensin II axis.
Choi J; Park S; Kwon TK; Sohn SI; Park KM; Kim JI
Int J Obes (Lond); 2017 Nov; 41(11):1702-1709. PubMed ID: 28720877
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production.
Yoon GE; Jung JK; Lee YH; Jang BC; In Kim J
Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):491-500. PubMed ID: 31655853
[TBL] [Abstract][Full Text] [Related]
3. Pathologic HDAC1/c-Myc signaling axis is responsible for angiotensinogen transcription and hypertension induced by high-fat diet.
Youn EK; Cho HM; Jung JK; Yoon GE; Eto M; Kim JI
Biomed Pharmacother; 2023 Aug; 164():114926. PubMed ID: 37244179
[TBL] [Abstract][Full Text] [Related]
4. Leptin Mediates High-Fat Diet Sensitization of Angiotensin II-Elicited Hypertension by Upregulating the Brain Renin-Angiotensin System and Inflammation.
Xue B; Yu Y; Zhang Z; Guo F; Beltz TG; Thunhorst RL; Felder RB; Johnson AK
Hypertension; 2016 May; 67(5):970-6. PubMed ID: 27021010
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
Zhao L; Chen CN; Hajji N; Oliver E; Cotroneo E; Wharton J; Wang D; Li M; McKinsey TA; Stenmark KR; Wilkins MR
Circulation; 2012 Jul; 126(4):455-67. PubMed ID: 22711276
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain.
Foti SB; Chou A; Moll AD; Roskams AJ
Int J Dev Neurosci; 2013 Oct; 31(6):434-47. PubMed ID: 23542004
[TBL] [Abstract][Full Text] [Related]
8. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
9. Central Renin-Angiotensin System Activation and Inflammation Induced by High-Fat Diet Sensitize Angiotensin II-Elicited Hypertension.
Xue B; Thunhorst RL; Yu Y; Guo F; Beltz TG; Felder RB; Johnson AK
Hypertension; 2016 Jan; 67(1):163-70. PubMed ID: 26573717
[TBL] [Abstract][Full Text] [Related]
10. Disruption of Planar Cell Polarity Pathway Attributable to Valproic Acid-Induced Congenital Heart Disease through Hdac3 Participation in Mice.
Duan HY; Zhou KY; Wang T; Zhang Y; Li YF; Hua YM; Wang C
Chin Med J (Engl); 2018 Sep; 131(17):2080-2088. PubMed ID: 30127218
[TBL] [Abstract][Full Text] [Related]
11. HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice.
Scholz B; Schulte JS; Hamer S; Himmler K; Pluteanu F; Seidl MD; Stein J; Wardelmann E; Hammer E; Völker U; Müller FU
Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007071. PubMed ID: 30879335
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases are critical regulators of the renin-angiotensin system during ureteric bud branching morphogenesis.
Song R; Van Buren T; Yosypiv IV
Pediatr Res; 2010 Jun; 67(6):573-8. PubMed ID: 20496471
[TBL] [Abstract][Full Text] [Related]
13. [Effect of histone acetylation/deacetylation imbalances on key gene of planar cell polarity pathway].
Duan HY; Zhang Y; Zhou KY; Wang C; Qiu DJ; Hua YM
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):475-483. PubMed ID: 28407839
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition.
Lv L; Sun Y; Han X; Xu CC; Tang YP; Dong Q
Brain Res; 2011 Jun; 1396():60-8. PubMed ID: 21439269
[TBL] [Abstract][Full Text] [Related]
15. Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach.
Sixto-López Y; Bello M; Correa-Basurto J
J Comput Aided Mol Des; 2020 Aug; 34(8):857-878. PubMed ID: 32180123
[TBL] [Abstract][Full Text] [Related]
16. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases.
Ferrari A; Fiorino E; Longo R; Barilla S; Mitro N; Cermenati G; Giudici M; Caruso D; Mai A; Guerrini U; De Fabiani E; Crestani M
Int J Obes (Lond); 2017 Feb; 41(2):289-298. PubMed ID: 27795551
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer.
Sun J; Piao J; Li N; Yang Y; Kim KY; Lin Z
FEBS J; 2020 May; 287(10):2118-2133. PubMed ID: 31692265
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of VPA on multiple myeloma U266 cell proliferation and regulation of histone acetylation].
Zhu YF; Ye BG; Shen JZ; Lin CM; Lin FA; Shen SF; Xu CB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):638-41. PubMed ID: 20561418
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.
Jia H; Pallos J; Jacques V; Lau A; Tang B; Cooper A; Syed A; Purcell J; Chen Y; Sharma S; Sangrey GR; Darnell SB; Plasterer H; Sadri-Vakili G; Gottesfeld JM; Thompson LM; Rusche JR; Marsh JL; Thomas EA
Neurobiol Dis; 2012 May; 46(2):351-61. PubMed ID: 22590724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
